Rafferty Asset Management
TSVT

Rafferty Asset Management’s 2seventy bio TSVT Stock Holding History

Rafferty Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-230,938
Closed -$2.34M – 1105
2023
Q2 		$2.34M Buy
230,938
+8,967
+4% +$94.9K 0.01% 603
2023
Q1 		$2.26M Buy
221,971
+90,390
+69% +$1.03M 0.02% 578
2022
Q4 		$1.23M Buy
131,581
+2,078
+2% +$29.3K 0.01% 706
2022
Q3 		$1.88M Buy
129,503
+42,633
+49% +$633K 0.02% 521
2022
Q2 		$1.15M Sell
86,870
-133,030
-60% -$1.81M 0.01% 600
2022
Q1 		$3.75M Buy
219,900
+39,121
+22% +$664K 0.02% 445
2021
Q4 		$4.63M Buy
+180,779
New +$5.64M 0.02% 413

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Rafferty Asset Management's TSVT Position: Q3 2023 in Review

Rafferty Asset Management sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 230,938 shares — an estimated $2.34M sold.

Rafferty Asset Management first reported a position in TSVT in Q4 2021 and held it in 7 quarters. The position peaked at $4.63M in Q4 2021. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Rafferty Asset Management reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 230,938 2seventy bio shares in Q3 2023, an estimated $2.34M.
  • Rafferty Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 7 quarters.
  • Rafferty Asset Management's 2seventy bio position peaked at $4.63M in Q4 2021.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.